Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
News
Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
NICE recommends Kymriah® for routine NHS use, offering immense benefits for those with resistant B-...
Read moreConsultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch